PRODUCT MONOGRAPH. PR. Cathflo. ® alteplase, recombinant . cell line into which the cDNA for alteplase has been genetically inserted. Read all of this leaflet carefully before you What Actilyse Cathflo is and what it is used for. 2. Contents of the pack and other information. 1. Drug monographs for CATHFLO ACTIVASE provide an overview of the drug Keeping the vial of Sterile Water for Injection upright, insert the piercing pin of the .
|Published (Last):||21 June 2017|
|PDF File Size:||2.14 Mb|
|ePub File Size:||20.97 Mb|
|Price:||Free* [*Free Regsitration Required]|
Slight foaming is not unusual; let the vial stand undisturbed to allow large bubbles to dissipate.
Cathflo Activase (alteplase) dose, indications, adverse effects, interactions from
Increased bleeding complications have been reported in pediatric patients receiving higher doses; therefore, some authors recommend initiating therapy at the lower end of the dosage range and increasing the dose only if necessary for adequate lysis.
Moderate Fish oil, omega-3 fatty acids inhibit platelet aggregation, caution is advised when fish oils are used concurrently with anticoagulants, platelet inhibitors, or thrombolytic agents. We have not had any problems related to this that I am aware of and in fact, I have seen catheters that did not work after 30 and 60 minutes, have great blood return after minutes.
In the following populations or conditions, the risks of bleeding with alteplase therapy are increased and should be weighed against the potential benefits: Slight foaming is not unusual; let the vial stand undisturbed to allow large bubbles to dissipate. Hypersensitivity, including urticaria, angioedema and anaphylaxis, pacmage been reported in association with use of Cathflo Activase.
Monitor patients treated with Cathflo Activase for signs of hypersensitivity and treat appropriately if necessary.
Moderate Platelet aggregation may be catflo by vilazodone due to platelet serotonin depletion, possibly increasing the risk of a bleeding complication e.
You may also report side effects to Genentech at Clinical practice guidelines recommend immediate systemic anticoagulation with unfractionated heparin in patients with acute limb ischemia due to arterial emboli or thrombosis.
I have seen no official recommendation and no study or data, but I have had multiple discussions about this practice as an effective alternative to catheter stripping or replacement due to fibrin sheath that does not respond to 2 hour dwell. All fields are required.
Submit the form below to share this with a friend or colleague. Cathfol An additive risk of bleeding may be seen in patients receiving thrombolytic agents and anticoagulants. Moderate Platelet aggregation may be impaired by vortioxetine due to platelet serotonin depletion, possibly increasing the risk of a bleeding complication e. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Severe Due to the increased bleeding risk, avoid concurrent use of apixaban with thrombolytic agents. The most frequent adverse reaction associated with all thrombolytics in all approved indications is bleeding.
The information contained in this pafkage of the site is intended for U. Cathflo Activase has not been studied in patients known to be at risk for bleeding events that may be associated with the use of thrombolytics.
Major Ginkgo biloba should be used cautiously inserrt patients taking thrombolytic agents. Upon binding to fibrin, the one-chain form of alteplase is converted to the two-chain form. In clinical trials, the most serious adverse events reported after treatment were sepsis, gastrointestinal bleeding, and venous thrombosis.
For multiple lumens, treat one lumen at a time. It appears that when combined in vitro, nitroglycerin enhances the degradation of alteplase.
Major During and after therapy, avoid the concomitant use of Yttrium Y ibrutumomab tiuxetan with drugs that interfere with coagulation such as thrombolytic agents; the risk of bleeding may be increased.
Withdraw 2 mL into glass vials and cryopreserve at degrees C for 2 weeks; then, thaw and maintain at 22 to 24 degrees C for 24 hours; then, store at degrees C for up to 19 days. Slight foaming upon reconstitution may occur; standing insedt for several minutes is sufficient to packge dissipation of any large bubbles.
Single-Use Vial Lytic Thrombolytic – Cathflo® Activase® (alteplase)
I must ask the question as I am hearing lots of rumble from my in-patient colleagues about Coadministration of betrixaban and thrombolytic agents may increase the risk of bleeding. Get useful tools to help you ensure and promote patency in your clinical practice. Excessive pressure should be avoided when Cathflo Activase is instilled into the catheter. Nitroglycerin may enhance the hepatic clearance of alteplase since alteplase plasma concentrations are lower in patients receiving concomitant nitroglycerin.
For neonates with cardioembolic acute ischemic stroke, anticoagulation for 3 months with cayhflo unfractionated heparin or a low molecular weight heparin is recommended. As with all catheterization procedures, care should be used to maintain aseptic technique.
Major An additive risk of bleeding may be seen in patients receiving thrombolytic agents with thrombin inhibitors. If Garlic supplements are taken, monitor appropriate parameters to attain proper clinical endpoints.